Keyphrases
Hematopoietic Stem Cell Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Chimeric Antigen Receptor T-cell Therapy
100%
Hematopoietic Cell Transplantation
40%
Malignancy
40%
Cell Therapy
40%
Chimeric Antigen Receptor T Cells (CAR-T)
40%
Therapeutic Modalities
40%
Immune Response
20%
Antigen-specific
20%
Hematological Malignancies
20%
High Dose
20%
Mantle Cell Lymphoma
20%
Host Cell
20%
Chemotherapy
20%
Multiple Myeloma
20%
Non-Hodgkin Lymphoma
20%
Follicular Lymphoma
20%
Fully Developed
20%
Disease-associated
20%
Large B-cell Lymphoma
20%
Genetic Engineering
20%
Immune Effector Cells
20%
Clinical Decision-making
20%
Immunotherapeutics
20%
Ongoing Clinical Trials
20%
Cytotoxic Chemotherapy
20%
Redirection
20%
Long-term Remission
20%
T-product
20%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
20%
Nonspecific Immune Response
20%
Lymphoma B-cell
20%
MHC-independent
20%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Cell Transplantation
100%
Chimeric Antigen Receptor T-Cell Immunotherapy
100%
Hematopoietic Cell
100%
Chimeric Antigen Receptor
42%
Cancer
28%
Cell Therapy
28%
Clinical Trial
14%
Antigen Specificity
14%
Hematologic Malignancy
14%
Mantle Cell Lymphoma
14%
Drug Megadose
14%
Non-Hodgkin Lymphoma
14%
Follicular Lymphoma
14%
Large-Cell Lymphoma
14%
Multiple Myeloma
14%
Effector Cell
14%
Host Cell
14%
Clinical Decision Making
14%
Cytotoxic Chemotherapy
14%
Acute B-Cell Lymphoblastic Leukemia
14%
Major Histocompatibility Antigen
14%
Diseases
14%